Showing results (361-370 of 1,188) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|October 26, 2022
Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stageJannik Labrenz, Dominic Edelmann, Jonas S Heitmann, et al.Pharmaceutical Statistics|July 17, 2015
Short notes on maximum likelihood inference for control-based pattern-mixture modelsYongqiang TangPharmaceutical Statistics|August 6, 2016
Model averaging inconcentration-QT analysesBernard Sébastien, David Hoffman, Clémence Rigaux, et al.Pharmaceutical Statistics|June 18, 2015
Characterization of dose-response for count data using a generalized MCP-Mod approach in an adaptive dose-ranging trialFrancois Mercier, Bjoern Bornkamp, David Ohlssen, et al.Pharmaceutical Statistics|August 3, 2021
Confidence intervals for exposure-adjusted rate differences in randomized trialsEmil Scosyrev, Abhijit PethePharmaceutical Statistics|August 5, 2021
Robust estimates of regional treatment effects in multiregional randomized clinical trials with semiparametric logistic modelAo Yuan, Chaojie Yang, Shilin Yu, et al.Pharmaceutical Statistics|May 18, 2021
Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing eventsRegina Stegherr, Claudia Schmoor, Michael Lübbert, et al.Pharmaceutical Statistics|July 1, 2015
Risk patterns in drug safety study using relative times by accelerated failure time models when proportional hazards assumption is questionable: an illustrative case study of cancer risk of patients on glucose-lowering therapiesEdmond S-W Ng, Olaf H Klungel, Rolf H H Groenwold, et al.Pharmaceutical Statistics|May 22, 2020
Investigating the appropriateness of different concordance measures in a time-to-event settingSamantha-Jo Caetano, Gregory PondPharmaceutical Statistics|April 23, 2020
Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation timesJunhao Liu, Jo Wick, Yu Jiang, et al.Pageof 119